Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development

Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development

Tuberculosis (TB), caused by respiratory infection with Mycobacterium tuberculosis, remains a major global health threat. The only licensed TB vaccine, the one-hundred-year-old Bacille Calmette-Guérin has variable efficacy and often provides poor protection against adult pulmonary TB, the transmissi...

Full description

Bibliographic Details
Main Authors: Zhidong Hu, Shui-Hua Lu, Douglas B. Lowrie, Xiao-Yong Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
tuberculosis
vaccine
viral vector
mucosal immunity
trained immunity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.895020/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.895020/full

Similar Items